TEDESCHI, ALESSANDRA
 Distribuzione geografica
Continente #
AS - Asia 408
EU - Europa 201
NA - Nord America 156
SA - Sud America 148
AF - Africa 14
Totale 927
Nazione #
SG - Singapore 161
US - Stati Uniti d'America 138
IT - Italia 119
BR - Brasile 114
CN - Cina 92
VN - Vietnam 64
HK - Hong Kong 35
DE - Germania 22
FI - Finlandia 19
KR - Corea 14
AR - Argentina 10
BD - Bangladesh 10
IN - India 9
EC - Ecuador 8
GB - Regno Unito 8
CA - Canada 7
CZ - Repubblica Ceca 6
RU - Federazione Russa 6
ZA - Sudafrica 6
MX - Messico 5
IQ - Iraq 4
PL - Polonia 4
PY - Paraguay 4
UA - Ucraina 4
VE - Venezuela 4
ID - Indonesia 3
NL - Olanda 3
PE - Perù 3
BH - Bahrain 2
CO - Colombia 2
EG - Egitto 2
JP - Giappone 2
MA - Marocco 2
PK - Pakistan 2
RO - Romania 2
TR - Turchia 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
ES - Italia 1
FR - Francia 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SE - Svezia 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 927
Città #
Florence 82
Singapore 71
Hong Kong 35
Boardman 25
Hefei 25
Hanoi 19
Beijing 18
Ho Chi Minh City 17
Dallas 16
Seoul 14
Helsinki 13
Munich 13
Ashburn 12
Noto 11
Sesto Fiorentino 11
São Paulo 9
Santa Clara 7
Falkenstein 6
Haiphong 6
New York 5
Porto Alegre 5
Turku 5
Dhaka 4
Los Angeles 4
Rome 4
Secaucus 4
Warsaw 4
Wuhan 4
Brooklyn 3
Guangzhou 3
Johannesburg 3
Montreal 3
Nova Iguaçu 3
Ogden 3
Rio de Janeiro 3
Shanghai 3
Zibo 3
Asunción 2
Bologna 2
Boston 2
Bucharest 2
Caruaru 2
Charlotte 2
Cleveland 2
Curitiba 2
Goiânia 2
Itabira 2
Itajaí 2
Lima 2
London 2
Lviv 2
Manama 2
Manaus 2
Montes Claros 2
Natal 2
Ninh Bình 2
Phoenix 2
Pomigliano d'Arco 2
Seattle 2
Sumaré 2
Surat 2
São Bernardo do Campo 2
Tây Ninh 2
Aarhus 1
Abidjan 1
Al Fayyum 1
Algiers 1
Ambato 1
Americana 1
Amman 1
Angra dos Reis 1
Ankara 1
Antalya 1
Aparecida de Goiânia 1
Araguaína 1
Araraquara 1
Araripina 1
Arequipa 1
Atibaia 1
Bandar Lampung 1
Banja Luka 1
Barra de São Francisco 1
Barreira 1
Basra 1
Batam 1
Belo Horizonte 1
Bhanga 1
Bishkek 1
Bismarck 1
Boa Vista 1
Brasília 1
Brent 1
Bryansk 1
Buon Ma Thuot 1
Buritis 1
Buôn Dơn 1
Bắc Giang 1
Campina Grande 1
Campos Belos 1
Cariacica 1
Totale 565
Nome #
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement 76
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib 72
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia 70
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 70
Ibrutinib in patients over 80 with chronic lymphocytic leukemia: a multicenter Italian cohort 69
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study 67
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature 65
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement 60
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 60
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real‐life multicenter Italian cohort 55
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model 54
Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort 52
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real‐life experience 50
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study 48
Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practice 41
Acalabrutinib in High‐Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real‐Life Experience 36
Totale 945
Categoria #
all - tutte 6.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.445


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202342 0 0 0 0 0 0 20 3 4 2 10 3
2023/2024132 1 2 27 38 11 14 11 5 4 1 1 17
2024/2025276 17 24 0 13 26 22 7 4 20 22 35 86
2025/2026495 119 49 48 86 188 5 0 0 0 0 0 0
Totale 945